Lamivudine And Zidovudine 31722-0506-60
- Manufacturer
- Camber Pharmaceuticals, Inc.
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- September 18, 2015
- Listing Expires
- December 31, 2026
- Application
- ANDA079124
Need to source Lamivudine And Zidovudine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lamivudine | 150 mg/1 |
| Zidovudine | 300 mg/1 |
Drug Class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
Selected Package
31722-0506-60Selected60 TABLET, FILM COATED in 1 BOTTLE (31722-506-60)
Other packages for this product(1)
500 TABLET, FILM COATED in 1 BOTTLE (31722-506-05)